Cyber
knife is a non-invasive, painless robotic radiosurgery system used in
the treatment of brain tumors such as malignant, and non-malignant
tumors. It is also considered to be a radiosurgery device that do not
require frame for targeting. It is also known as the synchrony system
or synchrony method that uses a combination of surgical placed
internal fiducials and light emitting optical fibers that is mounted
on the patient body where the optical fibers are tracked by infrared
tracking camera. Cyber knife radiosurgery benefit to patients who
have previously received large doses of radiation therapy. The cyber
knife radiosurgery treatment can be completed in 1 to 5 days
treatment sessions with each treatment session lasts between 30 to 90
minutes. It can be used alone to treat the brain metastases.
Request
For Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/683
The
cyber knife system comprises of diagnostic x-ray tube, 6 MV linear
accelerator, secondary collimator, robot gantry, silicon X-ray
detectors, and patient couch. Cyber knife systems has a Food and Drug
Administration (FDA) clearance for the treatment of tumors such as
head, neck cancers, spinal lesions, pancreas, and malignant tumors.
Potential benefits of the cyber knife system includes no incision, no
loss in blood, no pain, no overnight hospitalization, also it is
faster and more accurate and patient can breathe normally during
treatment. This treatment is based on the principle of destruction of
cancerous cells by distracting their DNA by radiation, helps to
slower the growth of cancerous cells.
Increase
in incidences of cancer around the globe is expected to support the
growth in cyber knife system market over the forecast period
Cyber
knife is known for its radiology accuracy of 0.5 mm to 1.1 mm, which
are used to treat cancerous cells or brain tumors. Geographically,
North America and Europe regions are projected to lead the demand for
cyber knife market due to the increase in geriatric population,
prevalence of chronic diseases and growing demand for less time
consuming treatments, increase in incidence of cancer and a shift
towards painless and non-invasive surgeries. As owing to the large
patient population pool in the countries such as China and India,
cyber knife market is projected to grow in the forecast period.
In
2016, according to the American Cancer Society, it was estimated
around 1,690,000 cases of cancer were diagnosed and around 596,000
cancer deaths occurred in the U.S. due to the increase in geriatric
population, lack of physical exercise, over weight an and smoking
accounts for high proportion of cancer worldwide, this is expected to
led the demand for the cyber knife system in the near future.
The
Major Key Players of Cyber Knife Market Includes:
Accuray
Incorporated, BrainLab, Elekta AB, Nucletron B.V., GE Healthcare,
Hitachi America, IBA Group, Mitsubishi Electric, Nordion, Philips
Healthcare, RaySearch, Sumitomo Heavy Industries, Varian Medical
Systems, Modus Medical Devices Inc., Varian Medical Systems
International AG, GE Healthcare, Koninklijke Philips N.V., Toshiba
Medical Systems Corporation, and Shenzhen GeneMDx Biotech. Co., Ltd.
Cyber
Knife Market Taxonomy:
Cyber
Knife Market by Application:
-
Tumor (lung, pancreatic, liver)
-
Cancer
-
Vascular malformation
-
Other
Cyber
Knife Market End-User:
-
Hospitals
-
Ambulatory surgical centers
-
Clinics
-
Others
Browse
Full Research Report @
https://www.coherentmarketinsights.com/ongoing-insight/cyber-knife-market-683
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment